Mobile Site ›

Autoimmune Dysautonomia Evaluation


Subscribe

Receive notification when new Hot Topics are published:

Clinical Utility of Autoimmune Dysautonomia Evaluation

Slide 16

February 2011

Seropositivity can help distinguish autoimmune dysautonomia from chemotherapy side effects. Finally, a rise in antibody titer in a previously seropositive patient can suggest cancer recurrence.

Clinical Utility

 


Jump to section:


Key